Akorn, Inc. has entered into an agreement to acquire Advanced Vision Research, Inc. (AVR), an OTC ophthalmic company, for $26 million in cash. AVR develops and markets eye care products under the brands TheraTears and MacuTrition for dry eyes, eyelid hygiene, contact lens comfort and eye nutrition. Last year, AVR had sales of $20 million. Akorn also plans to launch a new Consumer Health Division to enter the $1.2 billion OTC eye care market. Bruce Kutinsky, Pharm. D., will serve as president...